Antidepressants elevate GDNF expression and release from C6 glioma cells in a β-arrestin1-dependent, CREB interactive pathway
Authors:
Open Access
- 12 January 2011
- journal article
- research article
- Published by Oxford University Press (OUP) in International Journal of Neuropsychopharmacology
- Vol. 14 (10) , 1289-1300
Abstract
Glial cell line-derived neurotrophic factor (GDNF), essential for neuronal survival, plasticity and development, has been implicated in the mechanismKeywords
This publication has 58 references indexed in Scilit:
- Neurogenesis-Dependent and -Independent Effects of Fluoxetine in an Animal Model of Anxiety/DepressionNeuron, 2009
- Neurobiological mechanisms in major depressive disorderCanadian Medical Association Journal, 2009
- Future antidepressant targets: neurotrophic factors and related signaling cascadesDrug Discovery Today: Therapeutic Strategies, 2008
- Stress, Depression, and Neuroplasticity: A Convergence of MechanismsNeuropsychopharmacology, 2007
- Antidepressants Increase Glial Cell Line-Derived Neurotrophic Factor Production through Monoamine-Independent Activation of Protein Tyrosine Kinase and Extracellular Signal-Regulated Kinase in Glial CellsThe Journal of Pharmacology and Experimental Therapeutics, 2007
- Astroglial Plasticity in the Hippocampus is Affected by Chronic Psychosocial Stress and Concomitant Fluoxetine TreatmentNeuropsychopharmacology, 2005
- Transduction of Receptor Signals by ß-ArrestinsScience, 2005
- Multifaceted roles of β-arrestins in the regulation of seven-membrane-spanning receptor trafficking and signallingBiochemical Journal, 2003
- Classical and new roles of β-arrestins in the regulation of G-PROTEIN-COUPLED receptorsNature Reviews Neuroscience, 2001
- GDNF: a Glial Cell Line-Derived Neurotrophic Factor for Midbrain Dopaminergic NeuronsScience, 1993